» Liver Disease - Can-Fite Successfully Completed Phase I <b>Clinical</b> <b>...</b>
Pnina Fisman, CEO of Can-Fite, said that: “the successful completion of this phase I trial with CF102 promote Can-Fite to a status of a biotechnology company with 2 pipeline drugs in clinical…